A 52-year-old man with no history of cardiovascular disease attends for a routine check. He is a non-smoker, has well-controlled hypertension and a total cholesterol of 6.2 mmol/L, HDL 0.9 mmol/L. His calculated 5-year absolute CVD risk is 17%. What is the most appropriate pharmacological intervention to reduce his cardiovascular risk?